The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > LJL BioSystems, Inc.

LJL BioSystems, Inc.
 NEWS FROM THE STANDARD
Bradley's Appeal
Oct 25 1999 12:00 AM PDT

 PROFILE
LJL BioSystems is accelerating the pace of scientific discovery with high-throughput screening (HTS) instruments and fluorescence-based assay technologies. The firm, a subsidiary of Molecular Devices, began selling its first HTS product in 1998. LJL BioSystems' instruments, sold under the CRITERION brand, allow users to perform cellular and biochemical assays in multiple detection formats on up to 1,536 samples at a time. The company's proprietary FLARe technology uses long-lived fluorescent reagents; its reagents are designed for use with its HTS instruments. The firm also makes clinical diagnostic products for original equipment manufacturers.

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 9.90
1-Yr. Sales Growth: 125.0%
Employees: 91
Revenue per employee: $108,791.21

 KEY PEOPLE
• Lev J. Leytes
    CEO
• Larry Tannenbaum
    CFO

 CONTACT INFO
404 Tasman Dr.
Sunnyvale, CA 94089
US
Phone: 408-541-8787
Fax: 408-541-8786
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001